| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.019 | 0.8 |